Physician profile
Christopher R Johnson
NPI 1942237078
$723.68
in general payments reported to CMS, 2019-2025
17 companies · $83.55 in 2025
The $83.55 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.05 · 2020: $208 · 2021: $18.16 · 2022: $17.21 · 2023: $139 · 2024: $166 · 2025: $83.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $197.93 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $108.47 | 2023-2024 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $57.50 | 2019-2020 | |
| Amgen INC. | $51.20 | 2021-2023 | Prolia, Evenity |
| Radius Health, INC. | $50.00 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $48.37 | 2019-2020 | |
| Boston Scientific Corporation | $30.89 | 2025 | General - Therapies, Wavewriter Alpha Prime 16 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.50 | 2020-2023 | Jardiance |
| Lundbeck LLC | $23.90 | 2024 | Vyepti |
| Dexcom, INC. | $19.30 | 2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $18.12 | 2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $16.76 | 2020 | |
| Glaxosmithkline, LLC. | $16.24 | 2023 | Arexvy |
| Shield Therapeutics INC | $15.75 | 2023 | Accrufer |
| Philips North America LLC | $14.94 | 2025 | Ecc Solutions |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $13.31 | 2020 | |
| Pfizer INC. | $12.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.